Compare BNTX & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | WST |
|---|---|---|
| Founded | 2008 | 1923 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 20.2B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | WST |
|---|---|---|
| Price | $93.95 | $271.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $137.40 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 1.3M | 661.3K |
| Earning Date | 11-03-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | N/A | ★ 0.17 |
| EPS | N/A | ★ 6.75 |
| Revenue | ★ $3,698,814,972.00 | $3,017,900,000.00 |
| Revenue This Year | $2.36 | $7.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | ★ N/A | $39.63 |
| Revenue Growth | 3.70 | ★ 4.92 |
| 52 Week Low | $81.20 | $187.43 |
| 52 Week High | $129.27 | $348.90 |
| Indicator | BNTX | WST |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 49.70 |
| Support Level | $94.52 | $265.39 |
| Resistance Level | $97.35 | $274.56 |
| Average True Range (ATR) | 2.51 | 7.11 |
| MACD | -0.26 | -0.59 |
| Stochastic Oscillator | 3.07 | 38.85 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.